PACB
Pacific Biosciences of California
Stock NASDAQ – Stock Market Prices, News & Analysis
Pacific Biosciences of California Inc is a developer of DNA sequencing systems, aimed at ensuring a better understanding of biological systems.
Pacific Biosciences of California
PACB
Pacific Biosciences of California Inc is a developer of DNA sequencing systems, aimed at ensuring a better understanding of biological systems.
Price history of Pacific Biosciences of California
Price history of Pacific Biosciences of California
Performance & Momentum
Pacific Biosciences Q4 beats with strong growth, rising margins
Pacific Biosciences of California (Pacific Biosciences of California Inc) reported Q4 2025 results surpassing expectations, with revenue up 14% to $44.65M and an improved gross margin of 41%. Growth was driven by strong demand for consumables and increasing clinical adoption, particularly via its Revio and Vega sequencing platforms. The company forecasts 2026 revenue between $165M and $180M, reflecting strategic confidence despite a slightly higher-than-expected non-GAAP loss. These results bolster PacBio's position in genomics and should support its stock performance.
Strategic Analysis
Pacific Biosciences of California • 2026
Pacific Biosciences positions itself as an innovative player in DNA sequencing, offering advanced technologies for biotechnology research. Its model relies on technological differentiation to meet the growing needs in genomic analysis, primarily targeting laboratories and research centers.
Strengths
- Highly differentiated and recognized sequencing technology
- Strong recent growth with improved operational margins
- Positioned in an expanding sector linked to advancements in health and biotechnology
Weaknesses
- History of highly volatile stock performance with significant long-term losses
- Sensitivity to rapid technological changes and increased competition
Momentum
The current momentum is favorable, supported by quarterly results that exceed expectations and reflect robust business dynamics as well as better cost control. This positive trend indicates a gradual recovery, providing an encouraging strategic context for patient investors in a rapidly changing sector.
Similar stocks to Pacific Biosciences of California
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
